EyeGate Pharma Discusses Early Clinical Trials Success, Promising Pipeline, and Partnership Payouts
EyeGate CEO Stephen From reports positive results of Phase Ia/IIb trials of EGP-437, regulatory progress for its Ocular bandage gel, and potential fundraising plans.
Activity